Drug Database
AM

amoxicillin (Moxacin / amoxicillin, CSL)

✓ Approved

CSL Limited · 小分子 · 小分子

什么是 amoxicillin?

amoxicillin 是一种小分子,由CSL Limited研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Moxacin, amoxicillin, CSL
公司CSL Limited
药物类别小分子
给药途径Oral (PO)
状态Approved

治疗适应症

amoxicillin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsSalmonellosis✓ Approved

相关研究文献

PubMedBiosensors & bioelectronics2026-11-18

A microfluidic electrochemical immunosensor for dual detection of β-lactam antibiotics in milk and wastewater.

Kumari Surbhi S, Vergin Chantal C CC, Lange Thorid T, Devi Sarita S et al.

Rapid monitoring of β-lactam antibiotic residues in food and environmental-samples remains a significant challenge, as conventional analytical methods, although highly sensitive, are often labor-intensive, time-consuming, and dependent on sophisticated instrumentation. Herein, we present a novel microfluidic electrochemical immunosensing platform based on an easy-to-synthesize conductive Au@ACM-10 metal-organic framework nanocomposite coupled with 3-aminopropylphosphonic acid (APPA)-assisted functionalization of the MOF. The resulting platform establishes a robust dual-recognition system capable of ultrasensitive detection of both amoxicillin (AMX) and ampicillin (AMP) within a rapid 10-min response time. Under optimized conditions, the immunosensor achieved excellent analytical performance for AMX (LOD 1.211 ng/mL; LOQ 1.86 ng/mL; sensitivity 213.9 μA/log(ng/mL)-1) and AMP (LOD 1.213 ng/mL; LOQ 1.90 ng/mL; sensitivity 211.4 μA/log(ng/mL)-1). The practical utility of the platform was successfully validated with ELISA-screened milk and spiked treated effluent wastewater yielding reliable recoveries with minimal matrix interference. Furthermore, integrating modified SPGEs within a microfluidic flow-cell system significantly reduced sample and electrolyte consumption while enhancing device portability. Overall, this proposed microfluidic platform offers a highly promising approach for the rapid, on-site monitoring of β-lactam antibiotic residues in food safety and environmental surveillance applications.

PMID 43051014
阅读全文 →
PubMedMediterranean journal of hematology and infectious diseases2026-11-18

Antimicrobial Management Following Positive Pneumococcal Urinary Antigen Testing in Hospitalized Community-Acquired Pneumonia: A Retrospective Cohort Study.

Donga Maria M, Gorgulho Ana A, Bartilotti Francisca F, Mbanze Dara D et al.

Pneumococcal urinary antigen testing (PUAT) rapidly supports pneumococcal etiology in community-acquired pneumonia (CAP), but how positive results are incorporated into antimicrobial management in routine care remains uncertain. To characterize antimicrobial stewardship actions implemented after a positive PUAT result became available in hospitalized adults with CAP, identify potential areas for improving guideline-concordant antimicrobial management, and compare clinical outcomes according to individual stewardship measures. We conducted a retrospective observational cohort study at a Portuguese tertiary hospital including adults hospitalized with CAP and positive PUAT between January 2020 and December 2024. The primary endpoint was antimicrobial spectrum narrowing. Post-PUAT atypical coverage optimization and intravenous-to-oral switch were analyzed separately. Among 332 episodes, antimicrobial spectrum narrowing occurred in 30 (9.0%), after a median of 3 days (Q1-Q3, 2-4). De-escalation to ampicillin or amoxicillin occurred in 7 episodes (2.1%). Post-PUAT atypical coverage optimization occurred in 158 episodes (47.6%) and intravenous-to-oral switch in 71 (21.4%). Narrowing and intravenous-to-oral switch were associated with shorter length of stay in unadjusted analyses, although these associations were exploratory and potentially influenced by clinical stability. In hospitalized PUAT-positive CAP, antimicrobial spectrum narrowing was uncommon, whereas atypical coverage optimization was the most frequent prescribing change. Structured post-result reassessment pathways may help improve guideline-concordant antimicrobial management.

PMID 43048189
阅读全文 →
PubMedJournal of pediatric hematology/oncology2026-11-18

Epidemiology of Bloodstream Infections and Impact of Antibiotic Prophylaxis: A 10-Year Experience at a Tertiary Care Pediatric Oncology-Hematology Center in Italy.

De Leonardis Francesco F, Rando Roberta R, Ronga Luigi L, Koronica Roberta R et al.

Bloodstream infections (BSIs) are a leading cause of morbidity and mortality in pediatric oncology-hematology patients. The local epidemiological landscape varies across centers, requiring continuous institutional surveillance. BSI episodes at a tertiary pediatric oncology-hematology center (Bari, Italy) were retrospectively reviewed over 10 years (2014 to 2024), analyzing microbiological spectrum, antimicrobial susceptibility, and the impact of 2 prophylactic policies: amoxicillin-clavulanate prophylaxis (2014 to 2019) versus its discontinuation (2019 to 2024). Among 568 newly diagnosed patients, 208 BSIs were documented in 144 (25.4%), with 93.8% monomicrobial. Gram-positive organisms predominated (61.6%), with coagulase-negative staphylococci as the most frequent isolates. Escherichia coli was the leading Gram-negative pathogen (9.5%). Eight fungal BSIs occurred exclusively in hematologic malignancies, half caused by Candida parapsilosis; 2 were polymicrobial. Peak C-reactive protein independently predicted Gram-negative BSI in multivariable analysis (OR: 1.005; 95% CI: 1.001-1.010; P<0.05), with limited discriminatory performance (AUC: 0.62). Blood culture positivity was significantly higher during prophylaxis (5.75% vs. 3.65%; P<0.001). Multidrug-resistant organisms remained rare (3.8%), with no methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci detected. BSI-related mortality was 1.4%, confined to Gram-negative and fungal episodes. Prophylaxis discontinuation was associated with lower positivity rates. An empirical escalation strategy ensured adequate coverage while minimizing antibiotic exposure, supporting its use in this setting.

PMID 43050585
阅读全文 →
PubMedClinical oral investigations2026-11-18

Oral Staphylococcus carriage in healthy adults: prevalence, antimicrobial resistance, temporal patterns, and oral-nasal comparisons.

Fonseca Maeva M, Sousa Marta M, Campos Carla C, Campos Joana J et al.

The oral cavity is increasingly recognized as a reservoir of Staphylococcus species, yet knowledge gaps remain regarding species diversity, antimicrobial resistance (AMR), overlap with nasal carriage, and colonization persistence. Therefore, this study characterized oral and nasal Staphylococcus colonization in healthy young adults and explored the oral cavity as a potential niche for AMR surveillance. Staphylococcus spp. from oral and nasal samples of 101 dentistry students were isolated and identified by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS). Antimicrobial susceptibility was assessed using EUCAST/CLSI guidelines. Longitudinal oral samples from a subgroup were analysed by Fourier Transform Infrared Spectroscopy-Attenuated Total Reflectance (FTIR-ATR) to explore strain persistence and turnover. Staphylococcus colonization was highly prevalent (oral: 91%; nasal: 95%), with 86% concurrent oro-nasal colonization. Staphylococcus epidermidis predominated in both niches. Resistance to ≥ 1 antimicrobial was detected in 80% of coagulase-negative staphylococci (CoNS) and 73% of oral Staphylococcus aureus carriers. Multidrug-resistant phenotypes were found in 10% of CoNS carriers. Although multidrug-resistant and methicillin-resistant S. aureus was not detected, oral S. aureus frequently showed resistance to commonly prescribed dental antibiotics (amoxicillin, erythromycin, and clindamycin). Resistance frequencies were comparable between niches. Oral species-specific colonization dynamics suggested temporal turnover among Staphylococcus warneri and persistence-like clustering for S. aureus in some participants. Oral cavity harbours diverse, frequently antimicrobial-resistant Staphylococcus populations at rates comparable to the nasal cavity. These findings support the oral cavity as a complementary niche for Staphylococcus carriage, highlighting its relevance for future AMR-surveillance strategies in dentistry and human health.

PMID 43049965
阅读全文 →
PubMedMolecules (Basel, Switzerland)2026-11-17

RETRACTED: Mohammadi et al. Removal of Amoxicillin from Aqueous Media by Fenton-like Sonolysis/H2O2 Process Using Zero-Valent Iron Nanoparticles. Molecules 2022, 27, 6308.

Mohammadi Leili L, Kamani Hossein H, Asghari Abolfazl A, Mohammadpour Amin A et al.

The journal retracts the article titled "Removal of Amoxicillin from Aqueous Media by Fenton-like Sonolysis/H2O2 Process Using Zero-Valent Iron Nanoparticles" [...].

PMID 43041160
阅读全文 →
PubMedInfection and drug resistance2026-11-17

Antimicrobial Resistance and Genomic Characteristics of Helicobacter pylori in Peptic Ulcer Disease: A Five-Case Series.

Fang Yunhui Y, Wang Kun K

Peptic ulcer disease is a well-established clinical manifestation of Helicobacter pylori infection. Antimicrobial resistance can compromise eradication, particularly after prior treatment. We describe a small surveillance-based case series integrating clinical history, phenotypic antimicrobial susceptibility, and genomic findings; the series was not designed to estimate population-level resistance patterns. Five patients with endoscopically documented gastric and/or duodenal ulcer and culture-confirmed H. pylori infection were identified during routine clinical microbiological surveillance from March 2023 to April 2024. Clinical data, Minimum Inhibitory Concentration (MIC)-based antimicrobial susceptibility, selected variants in resistance-related loci, virulence-associated genes, genome assembly characteristics, and a core-genome alignment-based comparative overview were analyzed descriptively; no inferential statistical testing was performed. The five patients were 25-51 years old and had endoscopically documented gastric and/or duodenal ulcers; concomitant gastritis or mucosal erosion was recorded separately. Four patients had documented prior eradication exposure, whereas treatment history was incomplete for one. All five isolates were resistant to clarithromycin and metronidazole and susceptible to levofloxacin, tetracycline, and rifampicin; two were also resistant to amoxicillin and met the study definition of multidrug resistance. All isolates carried 23S rRNA substitutions including the established clarithromycin resistance-associated A2147G substitution, whereas no gyrA resistance-associated substitution was detected. cytotoxin-associated gene A (cagA) was detected in all five isolates. Draft genome sizes ranged from 1.55 to 1.65 Mb, with GC contents of 38.54-38.82%. In the descriptive core-genome alignment-based tree, isolates 207, 318, and 221 formed a relatively close branch, whereas isolates 171 and 317 were more distinct. These genomic relationships were not interpreted as evidence of epidemiological clustering. This descriptive five-case series illustrates heterogeneous case-level antimicrobial susceptibility and genomic profiles in ulcer-associated H. pylori infection. The observations are not population-level resistance estimates, but they support the clinical value of culture-based susceptibility testing and/or validated molecular resistance detection for individualized management, particularly after prior eradication treatment.

PMID 43041343
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多amoxicillin